International Marijuana Business News – Europe
The German government published key details of its plan to legalize and regulate adult-use cannabis, including what Health Minister Karl Lauterbach described as “complete” cultivation within the country.
Germany’s recreational cannabis market should impose a cap on potency and rely on domestic cultivation, according to preliminary proposals for the planned recreational market by the country’s Ministry of Health.
Australian cannabis producer Little Green Pharma struck a deal to supply high-THC medical marijuana to Cologne, Germany-based Cannamedical.
International medical cannabis company Akanda Corp. says its shares could be delisted from the Nasdaq Capital Market after the stock exchange gave notice that the bid price of Akanda’s shares had fallen below its required minimum.
British American Tobacco (BAT) has taken a noncontrolling minority stake in German cannabis company Sanity Group for an undisclosed sum, the multinational tobacco giant announced Monday.
Germany imported a record amount of cannabis for medical sales and scientific use in the first half of this year, putting the European Union’s biggest market on pace to match or possibly surpass 2021’s total.
German government officials are questioning the veracity of some key facts in a recent news release by cannabis producer Tilray Brands, telling MJBizDaily their meeting with Tilray representatives was “a one-time conversation” and “not part of the preparatory phase” of marijuana legalization.
